RESUMO
Dolphin Morbillivirus (DMV), Toxoplasma gondii and Brucella ceti are pathogens of major concern for wild cetaceans. Although a more or less severe encephalitis/meningo-encephalitis may occur in striped dolphins (Stenella coeruleoalba) and bottlenose dolphins (Tursiops truncatus) infected by the aforementioned agents, almost no information is available on the neuropathogenesis of brain lesions, including the neuronal and non-neuronal cells targeted during infection, along with the mechanisms underlying neurodegeneration. We analyzed 5-lipoxygenase (5-LOX) expression in the brain of 11 striped dolphins and 5 bottlenose dolphins, affected or not by encephalitic lesions of various degrees associated with DMV, T. gondii and B. ceti. All the 8 striped dolphins with encephalitis showed a more consistent 5-LOX expression than that observed in the 3 striped dolphins showing no morphologic evidence of brain lesions, with the most prominent band intensity being detected in a B. ceti-infected animal. Similar results were not obtained in T. gondii-infected vs T. gondii-uninfected bottlenose dolphins. Overall, the higher 5-LOX expression found in the brain of the 8 striped dolphins with infectious neuroinflammation is of interest, given that 5-LOX is a putative marker for neurodegeneration in human patients and in experimental animal models. Therefore, further investigation on this challenging issue is also needed in stranded cetaceans affected by central neuropathies.
Assuntos
Araquidonato 5-Lipoxigenase/análise , Golfinho Nariz-de-Garrafa , Encéfalo/enzimologia , Encéfalo/patologia , Encefalite/veterinária , Stenella , Animais , Western Blotting , Encéfalo/microbiologia , Encéfalo/virologia , Brucella/patogenicidade , Brucelose/microbiologia , Brucelose/patologia , Brucelose/veterinária , Encefalite/enzimologia , Encefalite/virologia , Meningoencefalite/enzimologia , Meningoencefalite/patologia , Meningoencefalite/veterinária , Morbillivirus/patogenicidade , Infecções por Morbillivirus/veterinária , Infecções por Morbillivirus/virologia , Toxoplasma/patogenicidade , Toxoplasmose Animal/enzimologia , Toxoplasmose Animal/patologiaRESUMO
Bluetongue (BT) is non-contagious, vector-borne viral disease of domestic and wild ruminants, transmitted by midges (Culicoides spp.) and is caused by Bluetongue virus (BTV). BTV is the type species of the Orbivirus genus within the Reoviridae family and possesses a genome consisting of 10 double-stranded RNA segments encoding 7 structural and 4 nonstructural proteins. Viral Protein 7 (VP7) is the major sera group-specific protein and is a good antigen candidate for immunoenzymatic assays for the BT diagnosis. In our work, BTV-2 recombinant VP7 (BTV-2 recVP7), expressed in Spodoptera frugiperda (Sf9) cells using a baculovirus system, was produced and purified by affinity chromatography from the supernatant of infected cell culture. The use of the supernatant allowed us to obtain a high quantity of recombinant protein with high purity level by an easy one-step procedure, rather than the multistep purification from the pellet. RecVP7-BTV2 was detected using a MAb anti-BTV in Western blot and it was used to develop an immunoenzymatic assay.
Assuntos
Baculoviridae/metabolismo , Vírus Bluetongue/genética , Vírus Bluetongue/isolamento & purificação , Proteínas do Core Viral/isolamento & purificação , Proteínas do Core Viral/metabolismo , Animais , Cromatografia de Afinidade , Ensaio de Imunoadsorção Enzimática , Expressão Gênica , Vetores Genéticos , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Células Sf9 , Proteínas do Core Viral/genéticaRESUMO
The role of the mitochondrial permeability transition (MPT) in the killing of HeLa cells by staurosporine (STR) was assessed with the use of bongkrekic acid (BK), an inhibitor of the MPT. BK prevented cell killing as well as biochemical manifestations of the MPT: (a) the loss of the mitochondrial membrane potential (deltapsim); (b) the release of cytochrome c from the intramembranous space to the cytosol; and (c) the release of malate dehydrogenase from the mitochondrial matrix. Stable transfectants that overexpressed Akt were also resistant to cell killing and did not develop an MPT. STR inhibited the phosphorylation of Bad, whereas Bad phosphorylation was preserved in cells that overexpress Akt. In wild-type HeLa cells treated with STR, the content of Bax in the cytosol decreased as that in the mitochondria increased, a result that was again prevented by overexpression of Akt. Bid accumulation in the mitochondria with STR was not affected by overexpression of Akt. The pan-caspase inhibitor Z-Val-Ala-Val-Asp(OMe) fluoromethylketone prevented cell killing bu not induction of the MPT. The data document the central role of the MPT in the killing of HeLa cells by STR. The data are consistent with the hypothesis that induction of the MPT is a consequence of the movement of Bax to the mitochondria. Phosphorylation of Bad prevents Bax translocation. Caspases participate in the events related to cell killing that occur subsequent to induction of the MPT.
Assuntos
Apoptose/efeitos dos fármacos , Apoptose/fisiologia , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/fisiologia , Proteínas Serina-Treonina Quinases , Proteínas Proto-Oncogênicas c-bcl-2 , Estaurosporina/farmacologia , Ácido Bongcréquico/farmacologia , Inibidores de Caspase , Permeabilidade da Membrana Celular/efeitos dos fármacos , Permeabilidade da Membrana Celular/fisiologia , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Grupo dos Citocromos c/metabolismo , Inibidores Enzimáticos/farmacologia , Células HeLa , Humanos , Malato Desidrogenase/metabolismo , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Mitocôndrias/metabolismo , Proteínas Proto-Oncogênicas/biossíntese , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas c-akt , Estaurosporina/antagonistas & inibidores , Transfecção , Proteína X Associada a bcl-2RESUMO
Administration of N-hydroxy-2-acetylaminofluorene (N-OH-AAF) to rats inhibits liver nuclear RNA synthesis. This effect is reflected in an in vitro inhibition of RNA synthesis by isolated whole nuclei. The decreased RNA synthesis can be accounted for entirely by an inhibition of the RNA polymerase activities quantitatively solubilized and partially purified from these nuclei. Both nucleolar and nucleoplasmic polymerases are affected. A similar inhibition of the polymerases was demonstrated in intact nuclei by inactivating the endogenous template with actinomycin D and assaying the polymerases with an added exogenous template, poly(deoxyadenylate-deoxythymidylate). Chromatin was prepared from similar nuclear preparations by two methods, differing in the extent to which they remove endogenous polymerase activity. Each chromatin preparation was transcribed with added Escherichia coli or partially purified rat liver nucleoplasmic RNA polymerase respectively. With either polymerase and either chromatin preparation, no inhibition of the template activity of chromatin isolated from N-OH-AAF-treated animals could be detected. It is concluded that N-OH-AAF is a potent inhibitor of rat liver nuclear RNA synthesis and that the mechanism of this inhibition is inactivation of the RNA polymerases. At the same time, N-OH-AAF leaves the chromatin template, at least quantitatively, intact for the synthesis of RNA. The implications of such an effect of N-OH-AAF on RNA synthesis are discussed.
Assuntos
RNA Polimerases Dirigidas por DNA/antagonistas & inibidores , Fluorenos/farmacologia , Hidroxiacetilaminofluoreno/farmacologia , Nucleotídeos de Adenina , Animais , Nucléolo Celular/enzimologia , Núcleo Celular/enzimologia , Cromatina/efeitos dos fármacos , Cromatografia por Troca Iônica , Dactinomicina/farmacologia , Depressão Química , Fígado/ultraestrutura , Polinucleotídeos/farmacologia , Ratos , Solubilidade , Moldes Genéticos , Nucleotídeos de Timina , Transcrição Gênica/efeitos dos fármacosRESUMO
Over the course of 4 hr, the metabolism of acetaminophen (APAP) by cultured rat hepatocytes resulted in a depletion of protein thiols and an accumulation of oxidized glutathione (GSSG) in the medium. With 20 mM APAP, arylation and the formation of glutathione mixed disulfides accounted for a loss of 22% of the total protein thiols in the absence of any loss of viability. With 20 mM APAP and an inhibition of glutathione reductase by 1.3-(2-chloroethyl)-1-nitrosourea (BCNU), protein thiols were depleted by 40% by arylation and the formation of glutathione mixed disulfides, again without a loss of viability. With 20 mM APAP and BCNU in the presence of 20 mM deferoxamine, there was still little or no cell killing after 8 hr despite a loss now of almost 60% of the total protein thiols. These data do not support the hypothesis that a depletion of protein thiols is related to the toxicity of APAP. One millimolar APAP and BCNU killed 60% of the hepatocytes within 4 hr. In this circumstance, the loss of protein thiols was not attributable to either arylation by APAP metabolites or the formation of glutathione mixed disulfides. The antioxidant N,N'-diphenyl-phenylenediamine prevented the cell killing and the loss of protein thiols, a result implicating a role for lipid peroxidation in the depletion of protein-bound thiols. However, protein thiol depletion under these circumstances is not necessarily related to the lethal cell injury and most likely represents an epiphenomenon of the peroxidation of cellular lipids.
Assuntos
Acetaminofen/metabolismo , Fígado/metabolismo , Proteínas/metabolismo , Compostos de Sulfidrila/metabolismo , Acetaminofen/farmacologia , Animais , Carmustina/metabolismo , Carmustina/farmacologia , Células Cultivadas , Desferroxamina/farmacologia , Glutationa/análogos & derivados , Glutationa/metabolismo , Dissulfeto de Glutationa , Fígado/efeitos dos fármacos , Masculino , Fenilenodiaminas/farmacologia , Ratos , Ratos EndogâmicosRESUMO
The killing of isolated hepatocytes by N-acetyl-p-benzoquinone imine (NAPQI), the major metabolite of the oxidation of the hepatotoxin acetaminophen, has been studied previously as a model of liver cell injury by the parent compound. Such studies assume that the toxicity of acetaminophen is mediated by NAPQI and that treatment with exogenous NAPQI reproduces the action of the endogenously produced product. The present study tested these assumptions by comparing under identical conditions the toxicity of acetaminophen and NAPQI. The killing of hepatocytes by acetaminophen was mediated by oxidative injury. Thus, it depended on a cellular source of ferric iron; was potentiated by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), an inhibitor of glutathione reductase; and was sensitive to antioxidants. By contrast, the cytotoxicity of NAPQI was not prevented by chelation of ferric iron; was unaffected by BCNU; and was insensitive to antioxidants. Thus, the killing of cultured hepatocytes by NAPQI occurs by a mechanism different from that of acetaminophen. The killing by NAPQI was preceded by a collapse of the mitochondrial membrane potential and a depletion of ATP. Monensin potentiated the cell killing, and extracellular acidosis prevented it. These manipulations are characteristic of the toxicity of mitochondrial poisons, and are without effect on the depletion of ATP and the loss of mitochondrial energization. Thus, mitochondrial de-energization by a mechanism unrelated to oxidative stress is a likely basis of the cell killing by NAPQI. It is concluded that treatment of cultured hepatocytes with NAPQI does not model the cytotoxicity of acetaminophen in these cells.
Assuntos
Acetaminofen/toxicidade , Benzoquinonas/toxicidade , Iminas/toxicidade , Fígado/efeitos dos fármacos , Acidose/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Benzoflavonas/farmacologia , Carmustina/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Desferroxamina/farmacologia , Glutationa/metabolismo , Glutationa Redutase/antagonistas & inibidores , Técnicas In Vitro , Fígado/citologia , Modelos Biológicos , Monensin/farmacologia , Oxirredução , Fenilenodiaminas/farmacologia , Ratos , beta-NaftoflavonaRESUMO
The relationship between the metabolism of alpha-tocopherol (vitamin E) and ascorbate (vitamin C) was examined in cultured hepatocytes intoxicated with allyl alcohol. Alcohol dehydrogenase rapidly metabolizes allyl alcohol to the potent electrophile acrolein. Acrolein depletes the glutathione (GSH) content of the hepatocytes, thereby sensitizing the cells to the constitutive flux of activated oxygen species. Supplementation of the medium with 1 microM alpha-tocopherol phosphate (alpha-TP) prevents the 85% decline in cellular vitamin E seen after 16-18 hr in culture. In cells supplemented with alpha-TP, allyl alcohol produced a concentration-dependent decline in the cellular content of alpha-tocopherol, and these cells were more resistant to cell killing than hepatocytes not supplemented with alpha-TP. alpha-TP concentrations that raised the cellular alpha-tocopherol above the physiological level completely protected hepatocytes against the killing by allyl alcohol. In cells with physiological alpha-tocopherol, vitamin E declined within 30 min of exposure to allyl alcohol. This decrease paralleled the peroxidation of lipids, but preceded the decrease in cellular ascorbate. Under these conditions, a decline in ascorbate correlated with the loss of cell viability. Cells supplemented with at least 3 mM ascorbate prevented the decline in alpha-tocopherol. However, ascorbate acts as an independent antioxidant at these concentrations. In the absence of killing by allyl alcohol, the loss of cellular ascorbate did not depend on the presence or absence of cellular alpha-tocopherol. These data indicate that vitamins E and C act as separate antioxidants and that ascorbate does not regenerate the tocopheroxyl radical in cultured rat hepatocytes.
Assuntos
Antioxidantes/farmacologia , Ácido Ascórbico/farmacologia , Fígado/efeitos dos fármacos , Propanóis , Vitamina E/farmacologia , 1-Propanol/administração & dosagem , 1-Propanol/toxicidade , Animais , Antioxidantes/administração & dosagem , Antioxidantes/metabolismo , Ácido Ascórbico/administração & dosagem , Ácido Ascórbico/metabolismo , Morte Celular/efeitos dos fármacos , Células Cultivadas , Interações Medicamentosas , Fígado/citologia , Fígado/metabolismo , Malondialdeído/metabolismo , Ratos , Vitamina E/administração & dosagem , Vitamina E/metabolismoRESUMO
Ethoxycoumarin is metabolized by mixed-function oxidation to give 7-hydroxycoumarin (umbelliferone) and acetaldehyde, without formation of an intermediate electrophile. Ethoxycoumarin was found, nevertheless, to injure cultured rat hepatocytes. Male hepatocytes were more sensitive than female to ethoxycoumarin. Phenobarbital increased cell killing, and SKF 525A, an inhibitor of ethoxycoumarin metabolism, prevented it. Neither umbelliferone nor acetaldehyde were toxic. Cellular glutathione decreased and oxidized glutathione (GSSG) accumulated in the culture medium. Sulfhydryl reagents prevented the cell killing without inhibiting metabolism. Lipid peroxidation was detected prior to evidence of cell death, and the antioxidant N,N'-diphenyl-phenylenediamine prevented both the lipid peroxidation and cell killing without inhibiting metabolism. Inhibition of glutathione reductase with 1,3-bis(chloroethyl)-1-nitrosourea potentiated the cell killing without increasing metabolism. Pretreatment of the cells with the ferric iron chelator deferoxamine reduced cell killing, again without inhibiting metabolism. Ferric chloride restored the sensitivity of deferoxamine-pretreated hepatocytes to ethoxycoumarin. These data define a new experimental model in which lethal liver cell injury is dependent on the metabolism of ethoxycoumarin but unrelated to its two known metabolites. An oxidative stress accompanying the cytochrome P-450-dependent metabolism of ethoxycoumarin is proposed as the mechanism coupling metabolism to lethal cell injury.
Assuntos
Cumarínicos/toxicidade , Fígado/efeitos dos fármacos , Animais , Carmustina/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Cumarínicos/metabolismo , Desferroxamina/farmacologia , Glutationa/metabolismo , Glutationa Redutase/antagonistas & inibidores , Ferro/análise , Peróxidos Lipídicos/metabolismo , Oxirredução , Fenilenodiaminas/farmacologia , Proadifeno/farmacologia , Ratos , Ratos EndogâmicosRESUMO
The H2O2 generated by menadione kills cultured hepatocytes by a mechanism that depends in large part on a cellular source of ferric iron. Chelation of this iron by deferoxamine reduced by two-thirds the number of dead cells without any effect on the loss of 30% of total protein thiols, the formation of protein mixed disulfides, or the accumulation of oxidized glutathione (GSSG). The loss of protein thiols was accounted for by the formation of glutathione mixed disulfides from GSSG and the arylation of protein nucleophiles by menadione. Nevertheless, such a loss occurred despite the chelation of cellular iron and a substantial reduction in the extent of cell killing. With the H2O2 generated by glucose oxidase, lipid peroxidation and a loss of 40% of the total protein thiols accompanied the cell killing within 1 hr. Deferoxamine, superoxide dismutase and the antioxidant N,N'-diphenyl phenylenediamine (DPPD) prevented the cell killing and two-thirds of the loss of protein thiols. Peroxidation of liver microsomes in vitro with ADP:Fe3+ similarly depleted protein thiols, an effect that was prevented by DPPD. The supernatant fraction from the peroxidation assay depleted the protein thiols of cultured hepatocytes without an effect on viability. Thus, lipid peroxidation accounted for the major part of the loss of protein thiols with glucose oxidase. The 10-15% decrement in protein thiols after 1 hr that occurred in the absence of cell killing reflected the formation of glutathione mixed disulfides. Finally, in the presence of DPPD, glucose oxidase killed 75% of the cells between 1 and 3 hr without any further change in protein thiols. Thus, under the conditions studied, the depletion of protein thiols by the three mechanisms, namely lipid peroxidation, formation of glutathione mixed disulfides, and arylation, does not necessarily have a causal relationship to the killing of cultured hepatocytes.
Assuntos
Sobrevivência Celular/efeitos dos fármacos , Glutationa/análogos & derivados , Peróxido de Hidrogênio/metabolismo , Fígado/efeitos dos fármacos , Animais , Células Cultivadas , Desferroxamina/farmacologia , Dissulfetos/metabolismo , Compostos Férricos/metabolismo , Glucose Oxidase/metabolismo , Glutationa/metabolismo , Dissulfeto de Glutationa , Peróxido de Hidrogênio/toxicidade , Quelantes de Ferro/metabolismo , Peróxidos Lipídicos/metabolismo , Fígado/metabolismo , Masculino , Oxirredução , Fenilenodiaminas/farmacologia , Ratos , Ratos Endogâmicos , Vitamina K/farmacologiaRESUMO
Disulfiram is a potent antioxidant that prevented the peroxidation of microsomal phospholipids induced by ADP/Fe3+ at concentrations as low as 1 microM. However, disulfiram had a biphasic action when used to assess the role of lipid peroxidation in the killing of cultured hepatocytes by an acute oxidative stress. At a relatively low concentration (10 microM), the antioxidant activity of disulfiram predominated, and there was protection against the killing of the hepatocytes by allyl alcohol, tert-butyl hydroperoxide, hydrogen peroxide, and diethyl maleate. As the concentration of disulfiram was increased above 10 microM, the extent of protection progressively decreased. Thus, with higher concentrations of disulfiram, there was a second action whose consequence is to obscure the protective effect of the lower doses. With the agents studied, this additional and as yet undefined action of disulfiram leads to the killing of the hepatocytes by a mechanism that is unrelated to the peroxidation of lipids. This biphasic action of disulfiram must be appreciated in any attempt to use this compound to assess the role of lipid peroxidation in toxic cell injury.
Assuntos
Dissulfiram/farmacologia , Peróxido de Hidrogênio/farmacologia , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/citologia , Maleatos/farmacologia , Microssomos Hepáticos/metabolismo , Peróxidos/farmacologia , Propanóis , 1-Propanol/farmacologia , Animais , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Membranas Intracelulares/efeitos dos fármacos , Membranas Intracelulares/metabolismo , Fígado/efeitos dos fármacos , Masculino , Microssomos Hepáticos/efeitos dos fármacos , Ratos , Ratos Endogâmicos , terc-Butil HidroperóxidoRESUMO
A cellular pool of transient ferric iron that is chelatable by deferoxamine, distinct from ferritin, and required for oxidative cell injury has been identified in cultured rat hepatocytes labeled with 59FeCl3. Pretreatment of hepatocytes with deferoxamine depleted the cellular pool of chelatable iron and protected the cells from an oxidative injury. Incubation of deferoxamine-pretreated hepatocytes in serum-free medium restored both the chelatable iron pool and the susceptibility to oxidative injury. Furthermore, inhibition of protein degradation with chymostatin prevented the restoration of both the chelatable pool and susceptibility to oxidative injury. The deferoxamine-chelatable iron pool was distinguished kinetically and immunochemically from the larger cellular pool of ferritin iron. The labeled iron in the deferoxamine-chelatable pool was transient, unlike either the total cellular uptake of 59Fe or its incorporation into ferritin, both of which increased with time of labeling. With pulse-chase labeling, the percentage of the total uptake of 59Fe that was represented by the deferoxamine-chelatable pool decreased. At the same time, the percentage represented by radioactivity immunoprecipitable as ferritin increased. Furthermore, immunoprecipitation of ferritin from the labeled lysates enriched the resulting immunosupernatants in deferoxamine-chelatable iron. The degree of enrichment for chelatable iron correlated with the percentage of the cellular label that was immunoprecipitable as ferritin. The deferoxamine-chelatable iron appears to represent a metabolically common pool of iron that is rapidly in transit through the cell. Extracellular iron entering the pool can be utilized for heme synthesis or stored in ferritin, whereas protein degradation releases storage iron into this pool.
Assuntos
Compostos Férricos/toxicidade , Animais , Sobrevivência Celular , Células Cultivadas , Desferroxamina/química , Compostos Férricos/química , Ferritinas/química , Técnicas In Vitro , Quelantes de Ferro/química , Fígado/citologia , Fígado/efeitos dos fármacos , Oxirredução , Peróxidos/toxicidade , Ratos , Ratos Sprague-Dawley , terc-Butil HidroperóxidoRESUMO
Primary cultures of rat hepatocytes were used to explore the mechanisms of the toxicity of aryl halides. The sensitivity of the hepatocytes to chloro-, bromo-, and iodobenzene was enhanced by inhibition of glutathione reductase with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). In each case, the increased cell killing depended on the metabolism of the toxicant, a result shown by the protective effect of SKF-525A, an inhibitor of mixed function oxidation. BCNU decreased the metabolism of [14C]bromobenzene and the covalent binding of its metabolites by 20%. Chelation by deferoxamine of a cellular source of ferric iron prevented the cell killing in the presence or absence of BCNU. Deferoxamine had no effect on the metabolism or the covalent binding of [14C]bromobenzene. Similarly, the antioxidant N,N'-diphenyl-p-phenylenediamine (DPPD) reduced the cell killing and had no effect on the metabolism of [14C]bromobenzene. Thus, the toxicity of the three aryl halides was manipulated in ways that modify the sensitivity of hepatocytes to an oxidative stress, and the changes in cell killing occurred without parallel changes in the metabolism of [14C]bromobenzene or the covalent binding of its metabolites.
Assuntos
Bromobenzenos/toxicidade , Clorobenzenos/toxicidade , Iodobenzenos/toxicidade , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/metabolismo , Oxigênio/metabolismo , Animais , Bromobenzenos/metabolismo , Carmustina/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Desferroxamina/farmacologia , Peróxido de Hidrogênio/farmacologia , Fígado/citologia , Fígado/efeitos dos fármacos , Masculino , Fenilenodiaminas/farmacologia , Piridinas/farmacologia , Ratos , Ratos EndogâmicosRESUMO
The toxicity of acetaminophen was studied in hepatocytes cultured from phenobarbital-induced male rats. Such cells were less sensitive to acetaminophen than similar ones cultured from animals induced with 3-methylcholanthrene. In both cases, the toxicity of acetaminophen depended on its metabolism. Inhibition of glutathione reductase with 1,3-(2-chloroethyl)-1-nitrosourea (BCNU) potentiated the toxicity of acetaminophen in the presence or absence of 100 mM acetone, an agent that activates the mixed function oxidation of the toxin. BCNU enhanced the rate and extent of the depletion of GSH in the presence or absence of acetone. Pretreatment of the hepatocytes with the ferric iron chelator deferoxamine or addition to the culture medium of the antioxidant N,N'-diphenyl-p-phenylenediamine prevented the toxicity of acetaminophen in the presence of BCNU whether or not there was acetone in the cultures. BCNU similarly potentiated the hepatotoxicity of acetaminophen in the intact, phenobarbital-induced rat. These data indicate that the mechanism of the killing of hepatocytes induced with phenobarbital is similar to that reported previously with hepatocytes prepared from animals induced with 3-methylcholanthrene. In both cases it would seem that the liver cells are killed by acetaminophen as a result of an oxidative stress that accompanies the metabolism of this hepatotoxin.
Assuntos
Acetaminofen/toxicidade , Carmustina/toxicidade , Fígado/efeitos dos fármacos , Acetona/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Desferroxamina/farmacologia , Sinergismo Farmacológico , Indução Enzimática/efeitos dos fármacos , Glutationa/metabolismo , Fígado/metabolismo , Masculino , Maleatos/farmacologia , Metilcolantreno/farmacologia , Fenobarbital/farmacologia , Fenilenodiaminas/farmacologiaRESUMO
Sensitivity of cultured hepatocytes to acetaminophen was induced by pretreatment of the rat with 3-methylcholanthrene. Under these conditions, 10 uM B-naphthoflavone but not SKF-525A prevented the cell killing, indicating dependence on metabolism. Inhibition of glutathione reductase by 50 uM bis-chloro-nitrosourea, shown previously to increase the sensitivity of hepatocytes to an oxidative stress, potentiated the toxicity of acetaminophen without increasing the covalent binding of acetaminophen metabolites. Pretreatment of the hepatocytes with the ferric iron chelator deferoxamine, known to reduce the sensitivity of hepatocytes to an oxidative stress, prevented the cell killing without reducing covalent binding. Addition of ferric chloride to the culture medium restored the sensitivity of the cells to acetaminophen, again without effect on the extent of covalent binding. These data demonstrate that the toxicity of acetaminophen can be dissociated from the covalent binding of its metabolites and support the conclusion that the hepatocytes were lethally injured by an oxidative stress accompanying the mixed function oxidase-dependent biotransformation of acetaminophen.
Assuntos
Acetaminofen/toxicidade , Fígado/efeitos dos fármacos , Oxigênio/metabolismo , Acetaminofen/antagonistas & inibidores , Acetaminofen/metabolismo , Animais , Antioxidantes/farmacologia , Biotransformação/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Desferroxamina/farmacologia , Glutationa/metabolismo , Técnicas In Vitro , Fígado/metabolismo , Masculino , Oxirredução/efeitos dos fármacos , Ratos , Ratos EndogâmicosRESUMO
Cyclosporin A (CyA) and L-carnitine (LC) prevented the killing of cultured hepatocytes by anoxia and rotenone but not by cyanide. Neither CyA nor LC affected the rate or extent of the loss of the mitochondrial membrane potential or the rate or extent of the depletion of ATP. Atractyloside blocked the ability of both CyA and LC to protect, and D-carnitine antagonized the effect of LC but not that of CyA. Cell killing by cyanide was prevented when the phospholipase A2 inhibitor butacaine was added together with CyA. Butacaine by itself had no effect on cell killing. In a swelling assay with isolated rat liver mitochondria having a low calcium content, phenylarsine oxide or palmitoyl-CoA induced the inner membrane permeability transition when electron transport was inhibited by rotenone or cyanide. CyA prevented the permeability transition with rotenone but not with cyanide, and atractyloside reversed the effect of CyA. LC prevented the permeability transition occurring with palmitoyl-CoA plus rotenone but not with palmitoyl-CoA plus cyanide. Atractyloside and D-carnitine antagonized the protective effect of LC. Inhibition of the cyanide-dependent permeability transition in isolated liver mitochondria required the presence of both CyA and butacaine. These data document the close correlation between the effect of CyA and LC on the response of cultured hepatocytes to inhibition of mitochondrial electron transport and their ability to prevent the permeability transition in isolated mitochondria. It is concluded that the ability of CyA and LC to protect cultured hepatocytes is a consequence of their ability to prevent the mitochondrial permeability transition, indicating that this event is likely to be causally linked to the genesis of irreversible injury. Thus, cell death with anoxia or inhibitors of electron transport is related to a mitochondrial alteration by a mechanism that is independent of the maintenance of a membrane potential or cellular stores of ATP.
Assuntos
Carnitina/farmacologia , Morte Celular/efeitos dos fármacos , Hipóxia Celular , Ciclosporina/farmacologia , Membranas Intracelulares/metabolismo , Fígado/citologia , Mitocôndrias Hepáticas/efeitos dos fármacos , Ácido 4-Aminobenzoico/farmacologia , Aminobenzoatos , Animais , Arsenicais/farmacologia , Atractilosídeo/farmacologia , Células Cultivadas , Membranas Intracelulares/efeitos dos fármacos , Membranas Intracelulares/fisiologia , Cinética , Fígado/efeitos dos fármacos , Masculino , Potenciais da Membrana/efeitos dos fármacos , Mitocôndrias Hepáticas/metabolismo , Permeabilidade , Cianeto de Potássio/farmacologia , Ratos , Ratos Sprague-Dawley , Rotenona/farmacologia , Fatores de Tempo , para-AminobenzoatosRESUMO
The killing of cultured hepatocytes by tert-butyl hydroperoxide (TBHP) occurs by different mechanisms depending on the presence or absence of the antioxidant N,N'-diphenylphenylenediamine (DPPD). In either situation there is evidence of mitochondrial damage. The mitochondrial inner membrane potential is lost, a result determined by the release from the cells of the lipophilic cation [3H]triphenylmethylphosphonium (TPMP+). Deenergization of the mitochondria is accompanied by a loss of ATP. Oligomycin reduced ATP stores without release of TPMP+ or without effect on the viability of the hepatocytes over the same time course that TBHP killed the majority of the cells. Monensin, a H+/Na+ ionophore, potentiated the toxicity of tert-butyl hydroperoxide in the presence or absence of DPPD. By contrast, extracellular acidosis reduced the toxicity of tert-butyl hydroperoxide in the presence or absence of DPPD. Neither monensin nor extracellular acidosis affected the metabolism of tert-butyl hydroperoxide, the release of TPMP+, or the extent of the peroxidation of cellular lipids. These data document the presence of mitochondrial damage in hepatocytes intoxicated with TBHP in both the presence and absence of DPPD. Furthermore, the potentiation by monensin is readily explained by the proposal that mitochondrial deenergization is accompanied by an intracellular acidosis. Such acidosis tends to delay the development of lethal cell injury. The protective effect of extracellular acidosis supports this interpretation.
Assuntos
Mitocôndrias Hepáticas/efeitos dos fármacos , Peróxidos/toxicidade , Trifosfato de Adenosina/metabolismo , Animais , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Peróxidos Lipídicos/biossíntese , Masculino , Potenciais da Membrana/efeitos dos fármacos , Mitocôndrias Hepáticas/patologia , Monensin/toxicidade , Fenilenodiaminas/farmacologia , Ratos , Ratos Endogâmicos , Fatores de Tempo , terc-Butil HidroperóxidoRESUMO
1. We have examined whether the apparently ouabain-resistant fraction of cellular volume regulation in liver slices under isosmotic conditions is due to a failure of ouabain to cause complete inhibition of the coupled transport of Na+ and K+. The ion and water contents of rat and rabbit liver slices were altered by pre-incubation at 1 degree C and then allowed to recover at 38 degrees C, with or without ouabain or other inhibitors. The net movements of ions and water were determined during the recovery. The influx of 86Rb under steady-state conditions was taken as a measure of unidirectional influx of K+. 2. Concentrations of ouabain for half-maximal inhibition of 86Rb influx were 0.15 mM for rat and 0.15 microM for rabbit liver slices, with maximal inhibition at 2 mM and 10 microM respectively. Inhibition of net K+ reaccumulation closely followed inhibition of 86Rb influx. 3. The 86Rb influx persisting in the presence of maximally inhibiting concentrations of ouabain was not reduced by inhibitors of cellular respiration or glycolysis. 4. In rat liver slices, about 50% of net water extrusion was resistant to 2 mM-ouabain; rabbit liver showed a much smaller, but statistically significant, extrusion of water in the presence of 10 microM-ouabain. 5. In rat liver slices, a small, net uptake of K+ continued in the presence of amytal alone, when water extrusion was completely inhibited; by contrast, ouabain gave complete inhibition of K+ uptake while permitting 50% of the control water extrusion. 6. Isolated rat hepatocytes in primary culture were pre-incubated at 4 degrees C for 20 h. They recovered their original K+ content within 60 min of restoration to 37 degrees C. Ouabain, 1-2 mM, completely prevented this recovery. 7. The results imply that ouabain completely inhibits the coupled transport of Na+ and K+ in both rat and rabbit liver slices. Thus, the fraction of total water extrusion continuing in the presence of maximally inhibiting concentrations of ouabain is the consequence of a truly ouabain-resistant mechanism.
Assuntos
Fígado/metabolismo , Ouabaína/farmacologia , Potássio/farmacocinética , Animais , Técnicas In Vitro , Fígado/citologia , Fígado/efeitos dos fármacos , Masculino , Coelhos , Ratos , Ratos EndogâmicosRESUMO
Dose- and time-dependent killing of cultured rat hepatocytes was produced by aluminum maltolate (AlM), a neutral, water-soluble complex of aluminum 3-hydroxy-2-methyl-4H-pyran-4-one. Treatment with 10 mM AlM for 1 h killed 50% or more of the cells within 3 h. Removal of calcium from the culture medium or treatment with calcium channel blockers (verapamil, nifedipine, diltiazem) potentiated the cell killing. By contrast, inhibition by thapsigargin of the sequestration of intracellular calcium by the endoplasmic reticulum reduced the toxicity of AlM. In turn, activation of protein kinase C with 12-O-tetradecanoylphorbol 13-acetate or activation of protein kinase A with 8-[4-chlorophenyl-thio]adenosine 3',5'-cyclic monophosphate also reduced the toxicity of AlM. By contrast, inhibition of protein kinase activity by staurosporine potentiated the cell killing. Staurosporine, however, did not reverse the protection afforded by thapsigargin. Hepatocytes treated with AlM for 1 h were rescued by adding deferoxamine as late as 90 min following the removal of AlM, whereas pretreatment for 1 h with deferoxamine did not prevent the toxicity of AlM. ATP depletion did not precede loss of viability. Pharmacologic probes excluded oxidative stress as a mechanism of lethal injury by AlM, and inhibition of protein synthesis by cycloheximide did not protect the hepatocytes, thereby excluding activation of a cell death program. These data define a new model in which aluminum kills liver cells by a mechanisms distinct from previously recognized pathways of lethal cell injury. It is hypothesized that aluminum binds to cytoskeletal proteins intimately associated with the plasma membrane. This interaction eventually disrupts the permeability barrier function of the cell membrane, an event that heralds the death of the hepatocyte. The intracellular calcium ion concentration and protein phosphorylation may modify the interaction of aluminum with its critical targets. Alternatively, aluminum may inhibit the phosphorylation of cytoskeletal elements, thereby interfering with their function.
Assuntos
Alumínio/toxicidade , Cálcio/farmacologia , Fígado/efeitos dos fármacos , Compostos Organometálicos/toxicidade , Pironas/toxicidade , Animais , Morte Celular , Permeabilidade da Membrana Celular/efeitos dos fármacos , AMP Cíclico/análogos & derivados , AMP Cíclico/farmacologia , Desferroxamina/farmacologia , Relação Dose-Resposta a Droga , Fígado/citologia , Fígado/enzimologia , Masculino , Mitocôndrias/metabolismo , Estresse Oxidativo/fisiologia , Proteínas Quinases/metabolismo , Ratos , Ratos Sprague-Dawley , Terpenos/farmacologia , Acetato de Tetradecanoilforbol/farmacologia , Tapsigargina , Tionucleotídeos/farmacologia , Fatores de TempoRESUMO
Administration to rats of D-galactosamine (400 mg/kg) produces liver cell death that develops during the first 24 hours. Plasma membranes isolated within the first few hours from these animals show a 40% reduction in 5'-nucleotidase activity and a two-fold increase in maximum negative ellipticity determined by circular dichroism. Simultaneous administration of uridine prevents liver cell death and these early alterations in the plasma membranes. Uridine also prevents cell death if administered for up to 3 hours after galactosamine. The 5'nucleotidase activity reduced when uridine is administered for up to 2-1/2 hours after galactosamine. Changes in the liver calcium ion concentration accompany these plasma membrane alterations. Uridine will prevent and reverse the changes in calcium content in parallel to its ability to reverse the membrane alterations. The significance of these findings with respect to the mechanism of galactosamine-induced liver cell death is discussed.
Assuntos
Membrana Celular/efeitos dos fármacos , Doença Hepática Induzida por Substâncias e Drogas , Galactosamina , Fígado/patologia , Animais , Cálcio/análise , Membrana Celular/ultraestrutura , Sobrevivência Celular/efeitos dos fármacos , Dicroísmo Circular , Cobre/metabolismo , Relação Dose-Resposta a Droga , Eletroforese em Gel de Poliacrilamida , Feminino , Galactosamina/administração & dosagem , Galactosamina/farmacologia , Hepatopatias/patologia , Conformação Molecular , Nucleotidases/metabolismo , Biossíntese de Proteínas , RNA/biossíntese , Ratos , Fatores de Tempo , Uridina/administração & dosagemRESUMO
Acetaminophen killed cultured hepatocytes prepared from male rats induced with 3-methylcholanthrene by two distinct mechanisms. With 0.5 to 5 mM acetaminophen, cell killing within 4 h depended on the inhibition of glutathione reductase by 1,3-bis(chloroethyl)-1-nitrosourea (BCNU) and was accompanied by the peroxidation of cellular lipids as assessed by the accumulation of malondialdehyde. The antioxidant diphenylphenylenediamine (DPPD) prevented both the peroxidation of lipids and the death of the cells. By contrast, DPPD had no effect on the metabolism of acetaminophen as assessed by the extent of the covalent binding of [3H]acetaminophen; by the rate and extent of the depletion of glutathione; and by the accumulation of acetaminophen metabolites in the culture medium. It is concluded that the peroxidation of the phospholipids of cellular membranes is the mechanism whereby 0.5 to 5 mM acetaminophen lethally injures cultured hepatocytes. With 10-20 mM acetaminophen, cell killing at 4 h still depended on BCNU. However, the amount of malondialdehyde in the cultures progressively decreased in parallel with the decreasing ability of DPPD to protect the cells. With 20 mM acetaminophen, there was no evidence of lipid peroxidation, and DPPD had no protective effect. Thus, a second mechanism of lethal cell injury with 10-20 mM acetaminophen is independent of lipid peroxidation and insensitive to antioxidants.